Save time and get answers to complex questions with AI chat
Campath litigation germany?When genetic tenofovir alafenamide be available in us?Is guselkumab off patent in u s?Defense strategy against generic in niche market?When will tenofovir alafenide come off patent in canada?
See the DrugPatentWatch profile for Rinvoq
Rinvoq is upadacitinib. The FDA-approved prescribing information (the official label) is available from the FDA labeling resources: - DailyMed (official FDA labeling repository): search for “upadacitinib” or “Rinvoq” to view the current Prescribing Information. Link (search): https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=upadacitinib - Drugs@FDA (FDA labeling page): search for Rinvoq to access the label and PDFs of the Prescribing Information. If you’d like, I can pull the latest full label or summarize the main indications and safety notes for you. Which indication are you most interested in (e.g., rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, atopic dermatitis)?
Other Questions About Rinvoq :